| Name | ML364 |
|---|---|
| Synonyms | 2-[(4-methylphenyl)sulfonylamino]-N-(4-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide |
| Description | ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G. |
|---|---|
| Related Catalog | |
| Target |
USP2[1] |
| References |
| Molecular Formula | C24H18F3N3O3S2 |
|---|---|
| Molecular Weight | 517.541 |
| Exact Mass | 517.074 |
| Appearance | white solid |
| Storage condition | -20℃ |